GYEMSZI - MOB

Acta Physiologica Hungarica - 1988. 75. évf. 1. suppl.
Kapcsolódó tételek

101.			Neuroleptic profile in behavioral toxicological study
102.			New dihydropyridine compound (GYKI-46 544) with bradycardiac and vasodilatory effects
103.			A new immune-modulatory substance: CH-27584
104.			A new spectrum anxiolytic: 3-amino-4-ethylthio-7-Cl-quinoline HCL (EGIS 5278)
105.			Non-adrenergic non-cholinergic inhibitory innervation of the gastric fundus in streptozotocin-diabetic rats
106.			One-day kinetics of CaCl2 arrhytmogenicity following acute isoprenaline treatment
107.			Opiate peptidergic neurotransmission and cardiovascular and respiratory apparatus: experimental research with beta-endorphin and dermorphin on normotensive and hypertensive rats
108.			Oral zinc sulphate treatment in Wilson's disease
109.			Pain during injection and venous sequelae thiopentone versus propofol
110.			Papaverine blocks the early outward currents in Helix neurons
111.			Pharmacokinetics and tissue distribution of cyclosporin (CSA) in methylprednisolone-treated rats
112.			Pharmacological characterization of benzotriazole derivatives active on the muscarinic receptor
113.			Pharmacological studies on new gastrokinetic drugs
114.			Pharmacotherapy of opiate addiction in marche region
115.			Phentolamine antagonizes the hypoxia-induced suppression of myocardial contractility and sinu-atrial pacemaker activity
116.			Positive correlation of calcium concentration in cerebrospinal fluid and rectal temperature in rabbits
117.			Positive inotropic effects of GYKI-52 713 in conscious and anaesthetized animals
118.			Possibilities of pharmacological prevention of thrombin-induced coronary vasospasm
119.			Possible involvement of the antiserotoninergic and antihistaminergic activity in the anticataleptogenic effect of EGYT-2509
120.			Preclinical studies with compound GYKI-22441, a new long-acting neuroleptic phenothiazine
121.			Presynaptic control of striatal tyrosine hydroxylase activity by corticotropin - releasing factor
122.			Presynaptic effect of dexmedetomidine on cholinergic chemical transmission
123.			Prevention of diisopropylfluorophosphate (DFP)-induced lethalitiy by meptazinol and 9-amino-tetrahydroacridine (THA) in the mouse
124.			Prostaglandin releasing effect of pyrido-pyrimidines in the heart
125.			Quantitation of the enantiomers of furprofen in biological fluids by high-performance liquid chromatography
126.			Reflex inhibitory action of a non-NMDA type excitatory amino acid antagonist, GYKI 52466
127.			Relative selectivity of responsiveness to calcium antagonists in peripheral vascular smooth muscle of dogs
128.			The relevance of the calcium channel blocker Nimodipine in the therapy of therapy of cerebral aneurysms
129.			Repeated administration of (-)deprenyl leaves the mesolimbic dopaminergic activity unchanged
130.			Role of arachidonic acid metabolites in acute gastric lesions induced by indomethacin in rats
131.			Role of biochemical changes in the development of early ischemic and reperfusion arrhythmias
132.			The role of hypoglycemic sulphonylueras in arrhythmias contributing to the mortality in acute myocardial ischemia
133.			Rufloxacin, a new fluoroquinolone in biological fluids by high-performance liquid chromatography
134.			The selectivity of highly purified bovine liver angiohypotensin towards resistance vessels
135.			Sensitivity to endothelin-1 in mesenteric beds and aortic rings of 4-week-old spontaneously hypertensive rats
136.			The short term comparative study of antiulcer drugs with different modes of action in duodennal ulcer patients
137.			Sodium-azide-avoked noradrenaline release from peripheral nerves of rabbit pulmonary artery
138.			Somatostatin and cognitive functions: behavioral, neurochemical, and molecular biology studies
139.			Study of the predominant vascular potsynaptic alpha-adrenergic blocking capacity of GYKI-12 743 in isolated organs and pithed
140.			Systemically applied ruthenium red inhibits the stimulation of sensory receptors by capsaicin
141.			Transmembrane potentials of canine cardiac Purkinje fibres as affected by prajmaline
142.			Urine retention induced in rats by intra-spinal cord injection of colchicine as a tool to find new pharmacological treatments
143.			Variation in the potency of epithelial relaxant factor to modulate airway smooth muscle responsiveness in the function of different cholinergic agonists
144.			Vascular and cardiac electrophysiological activity of GYKI-12 743 in isolated tissue preparations
145.			Vasocortin inhibits Ca2+ influx and histamine release induced by concanavalin a in rat mast cells

Mind kijelölve: